Metformin treatment of antipsychotic-induced dyslipidemia: an analysis of two randomized, placebo-controlled trials
出版年份 2016 全文链接
标题
Metformin treatment of antipsychotic-induced dyslipidemia: an analysis of two randomized, placebo-controlled trials
作者
关键词
-
出版物
MOLECULAR PSYCHIATRY
Volume 21, Issue 11, Pages 1537-1544
出版商
Springer Nature
发表日期
2016-01-26
DOI
10.1038/mp.2015.221
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Differential Response to Risperidone in Schizophrenia Patients byKCNH2Genotype and Drug Metabolizer Status
- (2016) Juliane Heide et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effects of Metformin on Metabolite Profiles and LDL Cholesterol in Patients With Type 2 Diabetes
- (2015) Tao Xu et al. DIABETES CARE
- Insulin resistance and hypertension: new insights
- (2015) Manoocher Soleimani KIDNEY INTERNATIONAL
- Proof That Lower Is Better — LDL Cholesterol and IMPROVE-IT
- (2015) John A. Jarcho et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insulin Resistance, Small LDL Particles, and Risk for Atherosclerotic Disease
- (2014) Peter Toth Current Vascular Pharmacology
- Weight gain and antipsychotics: a drug safety review
- (2014) Richard Musil et al. Expert Opinion On Drug Safety
- Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin up-titration in Chinese patients with type 2 diabetes mellitus: study design and rationale of the vision study
- (2013) Li-Nong Ji et al. Cardiovascular Diabetology
- Molecular mechanism of action of metformin: old or new insights?
- (2013) Graham Rena et al. DIABETOLOGIA
- American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis: Executive Summary
- (2013) Paul Jellinger et al. Endocrine Practice
- Response to Warner Letter
- (2012) Fengyu Zhang et al. AMERICAN JOURNAL OF PSYCHIATRY
- Metformin for Treatment of Antipsychotic-Induced Amenorrhea and Weight Gain in Women With First-Episode Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Study
- (2012) Ren-Rong Wu et al. AMERICAN JOURNAL OF PSYCHIATRY
- Elevated Amylase and Lipase Levels in Patients Using Glucagonlike Peptide-1 Receptor Agonists or Dipeptidyl-Peptidase-4 Inhibitors in the Outpatient Setting
- (2012) Howard Lando et al. Endocrine Practice
- Dyslipidemias in the Prevention of Cardiovascular Disease: Risks and Causality
- (2012) Ian Graham et al. Current Cardiology Reports
- Insulin Resistance, Hyperglycemia, and Atherosclerosis
- (2011) Karin E. Bornfeldt et al. Cell Metabolism
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
- (2011) Marc De Hert et al. Nature Reviews Endocrinology
- Insulin resistance is associated with increased cholesterol synthesis, decreased cholesterol absorption and enhanced lipid response to statin therapy
- (2010) Michel R. Hoenig et al. ATHEROSCLEROSIS
- Managing Weight Gain and Metabolic Issues in Patients Treated With Atypical Antipsychotics
- (2009) David C. Henderson JOURNAL OF CLINICAL PSYCHIATRY
- Extended release metformin for metabolic control assistance during prolonged clozapine administration: A 14 week, double-blind, parallel group, placebo-controlled study
- (2009) Edgardo Carrizo et al. SCHIZOPHRENIA RESEARCH
- Metformin Addition Attenuates Olanzapine-Induced Weight Gain in Drug-Naive First-Episode Schizophrenia Patients: A Double-Blind, Placebo-Controlled Study
- (2008) Ren-Rong Wu et al. AMERICAN JOURNAL OF PSYCHIATRY
- Lifestyle Intervention and Metformin for Treatment of Antipsychotic-Induced Weight Gain
- (2008) Ren-Rong Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started